An interventional study of Andrositol Plus and Andrositol Plus in Male Infertility, sponsored by Andrology and Fertility Hospital of Hanoi. Status unknown at 1 site in Vietnam. Open to male participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2019-12-12.
Sponsored by Andrology and Fertility Hospital of Hanoi · Not applicable, Interventional, and Treatment
The aim of this study is to evaluate if Myo-inositol, N-Acetyl-Cysteine plus a cocktail of antioxidants could be able to increase spermatozoa parameters and reduce semen hyper-viscosity
According to the World Health Organization (WHO), the incidence of infertile couples is relatively high, with a range from 15% to 20% in the developed countries. In accordance with WHO, spermatogenesis disorders occur in almost 50% of all the cases of male infertility. In the recent decades, an unexplained reduction has been found, not only in sperm quality and quantity but also in the volume of the ejaculate. This evidence allows speculations on the number of male infertility factors, which will keep increasing in the future. An important impact on male infertility caused by environmental factors, such as bad habits (alcohol and smoking), body overload and in particular the reluctance of men undergoing prevention is widely reported. A reduced fertility is often related to a lower sperm motility. Over the recent years, the percentage of motile sperms in the ejaculate is constantly reducing. For these reasons, WHO, in the latest edition, indicated a percentage of sperms progressive motility less than 32% as a parameter of the reduced chance of getting pregnant spontaneously. The etiopathogenesis of male infertility is extremely complex, and the factors and processes causing these disorders in the reproduction are different. A common cause of reduced sperms motility seems to be related to the toxic action of reactive oxygen species (ROS). Pathological effects of free radicals in the male reproductive tract are associated with DNA fragmentation, lipid peroxidation, and apoptosis, and these lead to reduced fertility and miscarriages. Due to this evidence, antioxidant species were introduced in the management of male infertility. Between these molecules, Selenium and L-Arginine had shown a strong impact in contrasting ROS generation and restoring the oxidative status of the seminal environment. Myo-inositol (MI) is an isomer of the inositol's family. In nature are present 9 isomers of this sugar-like and MI represents the most abundant one. It plays a key role in more than one cellular pathways as FSH, insulin and TSH second intracellular messenger. It has been also demonstrated an important effect of MI in improving semen parameters such as motility, morphology, and quality, both in vitro and in vivo. From the reported studies, the effect of this isomer seems to be related to an improvement in the membrane potential of spermatozoa's mitochondria and in the reduction of the semen amorphous material that frequently impairs male fertility. Based on this evidence, recent scientific researches have been focused on the clinical use of MI in the management of male infertility caused by semen alterations. A further growing issue impairing male fertility is semen hyperviscosity (SHV). SHV is a condition that can seriously impair the physical and chemical characteristics of the seminal fluid and it can have a serious impact on sperm function. Worth of spreading, SHV seems to be associated with reduced sperm motility, possibly due to a 'trapping effect' that prevents normal sperm progression through the female genital tract. N-acetyl-L-cysteine (NAC) is a derivative of the naturally occurring amino acid L-cysteine that has free radical scavenging activity and it is also commonly used as a mucolytic agent. In addition to NAC antioxidant activity, Cifci et al. found it effective in reducing semen viscosity and its oxidative status as well as in increasing semen volume and spermatozoa motility.
2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.
This study's planned enrollment of 55 is below the median of 120 across 1,698 interventional studies indexed under Infertility.
Browse Infertility studies →This is the only study on the registry with Andrology and Fertility Hospital of Hanoi as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
all the patients will be treated for three months with a dietary supplement containing Myo-inositol, NAC, Folic acid, selenium, vitamin E, L-Arginine and L-Carnitine
Dietary Supplement: Andrositol Plus
Myo-inositol
N-Acetyl-Cysteine
Folic Acid
Selenium
L-arginine
L-carnitine
Vitamin E
change in sperm motility
spermatozoa motility will be evaluated through microscopical evalutation
Time frame: spermatozoa motility will be analyzed after 3 months of treatment
change in sperm morphology
spermatozoa morphology will be evaluated through microscopical evalutation
Time frame: spermatozoa morphology will be analyzed at the enrollment and after 3 months of treatmentanalyzed
change in sperm vitality
spermatozoa vitality will be evaluated through vitality test with methylene blue
Time frame: spermatozoa vitality will be analyzed after 3 months of treatment
change in sperm count
spermatozoa count will be evaluated through microscopical evalutation
Time frame: spermatozoa count will be 3 months of treatment
change in seminal fluid viscosity
Viscosity will be determined after ejaculation by gently aspirating semen into a 5 ml pipette and then producing semen drops.
Time frame: semen Hyper-viscosity will be analyzed after 3 months of treatment
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.